The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases
Crossref DOI link: https://doi.org/10.1007/s12551-016-0244-4
Published Online: 2016-12-06
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deshmukh, Prashant
Unni, Sruthi
Krishnappa, Gopinatha
Padmanabhan, Balasundaram
Funding for this research was provided by:
Indian Council of Medical Research (001/101/2015/00787)
Science and Engineering Research Board (SR/SO/BB-0108/2012)
License valid from 2016-12-06